Infectious disease
EBV BZLF1 44-52 (HLA-B*07:02) LPCVLWPVL
Product number: EP11214_5
€210.00*
Prices excl. VAT plus shipping
costs
Available, delivery time:
3 weeks
sterile and endotoxin free
Delivery Format: The product is supplied freeze dried.
Purity:
95% HPLC-MS
Caution:
For research use only. Not for use in humans.
Amount in mg
1
Description
LPCVLWPVL is a linear peptidic epitope studied as part of Trans-activator protein BZLF1 from Human herpesvirus 4 (Epstein Barr virus). This epitope has been studied for immune reactivity, tested in T cell assays.
TechData
| Sequence: | LPCVLWPVL |
| Gene: | BZLF1 |
| Delivery: | 3 weeks |
| C-Terminus: | OH |
| N-Terminus: | H |
| Amount: | 1 mg |
| Counterion: | TFA |
| Protein: | Trans-activator protein BZLF1 |
| UniProt Id: | P03206 |
| Species: | Epstein-Barr virus (EBV; Human herpesvirus 4) |
| Allele: | HLA-B*07:02 |
| Application: | T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
| Indication: | Infectious disease, Cancer, Neuroscience |
| Purity: | 95% HPLC-MS |
Skip product gallery
More EBV BZLF1 peptides
EBV BZLF-1 190-197 (HLA-B*08:01)
From
€105.00*
Antigen peptide RAKFKQLL for stimulation of human EBV BZLF-1(190-197)-specific CD8+ T-cells. The peptide is synthesised as it is presented by the MHC class I HLA-B*0801 allele. RAKFKQLL is a linear peptidic epitope (epitope ID53128) studied as part of Trans-activator protein BZLF1 from Human herpesvirus 4 (Epstein Barr virus). This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays
EBV BZLF-1 54-64 (HLA-B*35:01)
From
€133.20*
Antigen Peptide EBV BZLF1 HLA-B*3501 (EPLPQGQLTAY) for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays. EPLPQGQLTAY is a linear peptidic epitope (epitope ID13701) studied as part of Trans-activator protein BZLF1 from Human herpesvirus 4 (Epstein Barr virus). This epitope has been studied for immune reactivity tested in T cell assays and MHC ligand assays.